Patents
Last updated: September 10, 2026
Patent Portfolio and IP Licensing
SunLED Life Science develops and licenses proprietary photobiomodulation (PBM) technologies for lighting, automotive, display, wearable, medical, and related optical applications. The portfolio below summarizes representative granted patents and published patent applications supporting these technologies.
In particular, SunLED Life Science B.V. and its affiliates own granted patents and published patent applications in the U.S. and other jurisdictions worldwide relating to photobiomodulation (PBM), PBM lighting and illumination, PBM dose delivery and control, wearable PBM devices, and related optical technologies.
SunLED’s patent portfolio reflects dedicated research and development in PBM science and technology. Through licensing, SunLED makes selected technologies from this portfolio available to manufacturers and other partners seeking to incorporate PBM functionality into their own products, platforms, and applications.
Portfolio information
The granted patents and published applications are listed below solely for informational and licensing purposes, and this page does not constitute a U.S. virtual patent marking notice under 35 U.S.C. §287(a). For U.S. virtual patent marking information for licensed products, product families, and implementations manufactured or sold by licensees, visit: U.S. Patent Marking Notice.
Published patent applications are not issued patents unless and until granted. Inclusion of a published patent application on this webpage should not be understood as an indication that a patent has issued, or that any particular claim scope has been or will be granted.
SunLED welcomes inquiries from companies interested in licensing PBM and related optical technologies covered by this portfolio.
See our patents
SunLED Life Science’s patents and published applications are listed below.
Last updated: September 10, 2026
Patent / Publication No(s). | Jurisdiction(s) |
Issued Patents | |
US 12,186,578 B2 | United States |
EP 3895504 B1 | Austria, Belgium, Germany, Denmark, Finland, France, Hungary, Italy, the Netherlands, Norway, Poland, and Sweden |
CA 3,123,130 C | Canada |
CN ZL201980090392.6 | China |
JP 7282413 B2 | Japan |
KR 102659002 B1 | South Korea |
EP 4243926 B1 | Austria, Belgium, Switzerland, Cyprus, Germany, Denmark, Finland, France, the United Kingdom, Hungary, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Monaco, Montenegro, North Macedonia, Malta, the Netherlands, Norway, Poland, Sweden, Slovenia, and Türkiye |
JP 7860606 B2 | Japan |
Published applications | |
EP 4574204 A2 | Europe |
US 2025/0082954 A1 | United States |
KR 10-2024-0055143 A | South Korea |
US 2022/0288412 A1 | United States |
CN 114901355 A | China |
EP 4061482 A1 | Europe |
WO 2025/168535 A1 | International |
JP 2024-511631 A | Japan |
CN 117083988 A | China |
US 2026/0027383 A1 | United States |
EP 4565317 A1 | Europe |
JP 2025-525164 A | Japan |
KR 10-2025-0044309 A | South Korea |
CN 119630451 A | China |
WO 2024/028203 A1 | International |
EP 4750526 A1 | Europe |
KR 10-2026-0053284 A | South Korea |
CN 121586602 A | China |
WO 2025/021895 A1 | International |
US 2026/0069884 A1 | United States |
WO 2025/219311 A1 | International |
Additional patent applications may be pending in the U.S. and other jurisdictions including unpublished patent applications. The absence of a patent, patent application, product, or country from this page should not be interpreted as a waiver of any rights. This page may be updated periodically as patents issue, applications publish, applications are abandoned or withdrawn, or portfolio information otherwise changes.